Valuation: IRIDEX Corporation

Market Cap 20.37M 17.8M 16.34M 15.24M 28.89M 1.94B 29.38M 197M 76.25M 951M 76.47M 74.81M 3.28B P/E 2026 *
-23.4x
P/E 2027 * 58.5x
Enterprise Value 20.37M 17.8M 16.34M 15.24M 28.89M 1.94B 29.38M 197M 76.25M 951M 76.47M 74.81M 3.28B EV / Sales 2026 *
0.38x
EV / Sales 2027 * 0.36x
Free-Float
68.77%
Yield 2026 *
-
Yield 2027 * -
1 day-2.56%
1 week-4.24%
Current month-1.31%
1 month-3.42%
3 months+15.27%
6 months-3.42%
Current year-0.88%
1 week 1.12
Extreme 1.12
1.2
1 month 1.09
Extreme 1.09
1.2
Current year 0.95
Extreme 0.9496
1.65
1 year 0.87
Extreme 0.8688
1.65
3 years 0.78
Extreme 0.782
3.65
5 years 0.78
Extreme 0.782
9.46
10 years 0.78
Extreme 0.782
16.64
Manager TitleAgeSince
Chief Executive Officer 54 2024-09-30
Director of Finance/CFO 68 2018-12-17
Investor Relations Contact - -
Director TitleAgeSince
Chairman 60 2020-06-23
Director/Board Member 54 2018-08-31
Director/Board Member 66 2022-03-16
Date Insider Type Main position Quantity % Market Cap.
Jun. 12Tax

Chief Executive Officer

-3,990 0.0229%
Jun. 12Tax

Chief Financial Officer

-2,691 0.0155%
Jun. 11Buy

Chief Financial Officer

975 0.0056%
Change 5-day change 1-year change 3-year change Capi.($)
-2.56%-4.24%+24.15%-47.20% 20.37M
+1.50%+2.72%+21.45%+0.08% 191B
+5.09%+5.67%-21.87%+25.69% 143B
+1.33%+1.08%-3.56%-17.53% 137B
+4.49%+1.61%-56.66%-16.12% 64B
+2.04%+4.61%+21.86%+2.59% 52.97B
+1.39%+1.63%-26.28%-31.02% 43.82B
-1.36%-3.01%+8.92%+10.14% 37.67B
-0.77%-0.66%+6.39%+41.41% 37.13B
+0.86%+0.34%-14.40%-19.25% 29.5B
Average +1.20%+1.96%-4.00%-5.12% 73.55B
Weighted average by Cap. +2.20%+3.37%-4.06%+0.50%

Financials

2026 *2027 *
Net sales 53M 46.31M 42.53M 39.66M 75.18M 5.05B 76.45M 512M 198M 2.47B 199M 195M 8.53B 56.77M 49.6M 45.55M 42.48M 80.53M 5.4B 81.88M 548M 213M 2.65B 213M 209M 9.13B
Net income -795K -695K -638K -595K -1.13M -75.68M -1.15M -7.68M -2.98M -37.12M -2.99M -2.92M -128M 361K 315K 290K 270K 512K 34.37M 521K 3.49M 1.35M 16.86M 1.36M 1.33M 58.08M
Net Debt - -
Logo IRIDEX Corporation
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Employees
93
Date Price Change Volume
26-07-02 $1.130 -3.41% 24,330
26-07-01 $1.170 +2.18% 9,856
26-06-30 $1.145 +0.88% 23,577
26-06-29 $1.135 +0.44% 57,032
26-06-26 $1.130 -4.24% 29,320
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.170USD
Average target price
2.750USD
Spread / Average Target
+135.04%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRIX Stock